---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-033514"
form_type: "8-K"
ticker: "AIM"
cik: "0000946644"
company_name: "AIM ImmunoTech Inc."
filed_at: "2026-07-16T20:05:43+00:00"
generated_at: "2026-07-16T20:07:11.246292+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# AIM ImmunoTech shareholders approve reverse stock split and warrant/note conversion issuances

## Summary
- Special meeting held July 15, 2026; quorum of 10,671,690 shares (38.5%) present.
- Proposals 1-5 approved: issuance of >19.99% of shares upon exercise of Class H, I, J warrants and conversion of two promissory notes.
- Proposal 6 approved: reverse stock split at ratio up to 1-for-25, ratio at Board discretion.
- Proposal 7 approved: adjournment if needed to solicit additional proxies.

## SEC filing metadata
- accession: 0001493152-26-033514
- form_type: 8-K
- ticker: AIM
- cik: 0000946644
- company_name: AIM ImmunoTech Inc.
- filed_at: 2026-07-16T20:05:43+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946644/000149315226033514/0001493152-26-033514-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946644/000149315226033514/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-033514
- JSON: https://secwatch.observer/filing/0001493152-26-033514.json
- Plain text: https://secwatch.observer/filing/0001493152-26-033514.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.